OSAM
BHVN

O'Shaughnessy Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,600
Closed -$242K – 1495
2022
Q3 		$242K Sell
1,600
-686
-30% -$102K ﹤0.01% 1011
2022
Q2 		$333K Buy
2,286
+268
+13% +$34.2K 0.01% 825
2022
Q1 		$239K Buy
2,018
+30
+2% +$3.74K ﹤0.01% 1000
2021
Q4 		$274K Hold
1,988
– – ﹤0.01% 916
2021
Q3 		$277K Sell
1,988
-655
-25% -$81.8K 0.01% 885
2021
Q2 		$256K Buy
2,643
+5
+0.2% +$406 0.01% 911
2021
Q1 		$180K Sell
2,638
-584
-18% -$47.2K ﹤0.01% 969
2020
Q4 		$276K Buy
3,222
+3,201
+15,243% +$271K 0.01% 718
2020
Q3 		$1K Hold
21
– – ﹤0.01% 1848
2020
Q2 		$2K Buy
+21
New +$1.12K ﹤0.01% 1549
2020
Q1 		– Sell
-30
Closed -$2K – 2049
2019
Q4 		$2K Buy
+30
New +$1.49K ﹤0.01% 1706

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

O'Shaughnessy Asset Management's BHVN Position: Q4 2022 in Review

O'Shaughnessy Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 1,600 shares — an estimated $242K sold.

O'Shaughnessy Asset Management first reported a position in BHVN in Q4 2019 and held it in 11 quarters. The position peaked at $333K in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • O'Shaughnessy Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,600 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $242K.
  • O'Shaughnessy Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019 and held it in 11 quarters.
  • O'Shaughnessy Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $333K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.